| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.21B | 36.15B | 25.57B | 22.06B | 19.49B | 17.80B |
| Gross Profit | 14.55B | 19.54B | 9.52B | 7.70B | 6.69B | 6.62B |
| EBITDA | 14.69B | 18.11B | 8.96B | 7.94B | 6.16B | 4.12B |
| Net Income | 8.03B | 9.58B | 3.52B | 3.12B | 2.31B | 973.32M |
Balance Sheet | ||||||
| Total Assets | 95.99B | 80.97B | 61.47B | 57.21B | 53.17B | 50.42B |
| Cash, Cash Equivalents and Short-Term Investments | 11.65B | 5.38B | 3.27B | 3.55B | 3.15B | 3.81B |
| Total Debt | 34.93B | 25.26B | 19.54B | 18.96B | 17.72B | 17.26B |
| Total Liabilities | 53.28B | 44.04B | 31.61B | 29.87B | 28.23B | 27.62B |
| Stockholders Equity | 42.71B | 36.93B | 29.86B | 27.33B | 24.93B | 22.79B |
Cash Flow | ||||||
| Free Cash Flow | 10.08B | 7.30B | 4.71B | 3.89B | 3.86B | 4.94B |
| Operating Cash Flow | 10.12B | 7.40B | 4.85B | 3.97B | 3.91B | 4.98B |
| Investing Cash Flow | -15.44B | -9.98B | -4.91B | -2.88B | -2.66B | -6.77B |
| Financing Cash Flow | 7.90B | 3.42B | -977.84M | 60.30M | -929.02M | -66.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $25.23B | 22.44 | 10.46% | 2.51% | 12.29% | 13.13% | |
71 Outperform | $17.16B | 14.00 | 16.99% | 2.22% | -10.23% | -26.87% | |
70 Outperform | $2.82B | 21.69 | 13.73% | 2.64% | 10.28% | 13.56% | |
66 Neutral | $10.89B | 15.89 | 10.29% | 3.48% | 21.35% | 20.96% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | $2.60B | 19.06 | 8.19% | 2.88% | -2.60% | -33.78% | |
59 Neutral | $934.86M | 21.70 | 9.27% | 2.67% | 6.24% | 3.35% |
At a board meeting held on December 18, 2025, Sabesp’s directors unanimously approved the payment of R$1.798 billion in interest on equity to shareholders, reinforcing the company’s shareholder remuneration policy for the 2025 fiscal period. The board also approved a R$2.81 billion increase in capital stock via the capitalization of profit reserves, achieved through the issuance of 20,264,000 new common shares to existing shareholders at a ratio of 0.029646975 share per share held as of December 23, 2025, a move that strengthens Sabesp’s equity base while rewarding investors with additional shares and potentially improving the company’s financial flexibility and capital structure.
The most recent analyst rating on (SBS) stock is a Buy with a $29.00 price target. To see the full list of analyst forecasts on Companhia De Saneamento stock, see the SBS Stock Forecast page.
On December 2, 2025, SABESP announced a rate adjustment authorized by ARSESP Resolution No. 1,748/2025, resulting in a 10.6% increase in the equilibrium rate. This adjustment is attributed to factors such as lag in RAB recognition, operational expenses, and inflation, among others. The average rate applied to users will see a 6.5% increase, incorporating inflation and tax adjustments. This change reflects SABESP’s efforts to balance financial sustainability with service delivery, impacting stakeholders by potentially altering service costs and company profitability.
The most recent analyst rating on (SBS) stock is a Buy with a $29.50 price target. To see the full list of analyst forecasts on Companhia De Saneamento stock, see the SBS Stock Forecast page.
On December 2, 2025, SABESP announced that ARSESP Resolution No. 1,748/2025 has been published, allowing the company to implement an average rate adjustment of 6.5% for its services, effective January 1, 2026. This adjustment represents a 10.6% increase in the equilibrium rate, which is expected to impact the company’s financial performance and market positioning. SABESP has committed to providing further clarifications on the rate adjustment and will keep stakeholders informed of any developments.
The most recent analyst rating on (SBS) stock is a Buy with a $29.50 price target. To see the full list of analyst forecasts on Companhia De Saneamento stock, see the SBS Stock Forecast page.
On November 24, 2025, SABESP announced the validation of its Regulatory Asset Base (RAB) for 2023 and 2024 by the São Paulo State Public Services Regulatory Agency. The RAB for 2023 was validated at R$78.5 billion, while the RAB for 2024 was set at R$88.0 billion. This validation reflects adjustments for factors such as asset revaluation and inflation, impacting the company’s financial planning and regulatory compliance. The announcement is significant for stakeholders as it provides clarity on SABESP’s asset valuation, which is crucial for future investment and operational strategies.
The most recent analyst rating on (SBS) stock is a Buy with a $29.50 price target. To see the full list of analyst forecasts on Companhia De Saneamento stock, see the SBS Stock Forecast page.
SABESP reported its financial results for the quarter ending September 30, 2025, showing a significant increase in total assets to 95.98 billion reais from 80.98 billion reais at the end of 2024. Despite a decrease in net income from the same period last year, the company maintained a strong financial position with a net income of 2.16 billion reais for the quarter. This financial performance reflects SABESP’s ongoing efforts to enhance its operational efficiency and market positioning, which are crucial for its stakeholders.
The most recent analyst rating on (SBS) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Companhia De Saneamento stock, see the SBS Stock Forecast page.
In its third-quarter 2025 earnings report, Sabesp announced an adjusted earnings per share of R$1.88, up from R$1.72 in the same period last year, driven by operational improvements and increased investments. The company invested R$4.0 billion in the quarter, the highest ever for a single period, to support its universalization goals, resulting in significant progress in expanding water and sewage connections. Despite a decrease in net income due to changes in customer mix and financial asset bifurcation impacts, Sabesp’s strategic focus on infrastructure and operational efficiency has reinforced its market position and commitment to social impact.
The most recent analyst rating on (SBS) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Companhia De Saneamento stock, see the SBS Stock Forecast page.